Overview
Junhao Xu practices practicing medicine in Harbin, China.
His clinical expertise encompasses Endocardial Fibroelastosis, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Cancer.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Junhao Xu
Is Junhao Xu a top-rated expert for Endocardial Fibroelastosis?
MediFind is an objective health platform that identifies experts based on real-world data. Junhao Xu is classified as an Experienced expert for Endocardial Fibroelastosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Junhao Xu participate in research or clinical trials?
Yes. Junhao Xu has published 9 articles and abstracts on conditions like Endocardial Fibroelastosis. You can view a list of Junhao Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerMr. Xu isExperienced. Learn about EGFR Positive Lung Cancer.
- Endocardial FibroelastosisMr. Xu isExperienced. Learn about Endocardial Fibroelastosis.
- Lung CancerMr. Xu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)